Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

Yongsheng Ruan, Hye Na Kim, Heather A. Ogana, Zesheng Wan, Samantha Hurwitz, Cydney Nichols, Nour Abdel-Azim, Ariana Coba, Seyoung Seo, Yong Hwee Eddie Loh, Eun Ji Gang, Hisham Abdel-Azim, Chih Lin Hsieh, Michael R. Lieber, Chintan Parekh, Dhananjay Pal, Deepa Bhojwani, Donald L. Durden, Yong Mi Kim

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number766888
JournalFrontiers in Oncology
Volume11
DOIs
StatePublished - Dec 1 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • BRD4
  • PI3Kδ
  • SF2535
  • acute lymphoblastic leukemia
  • c-Myc
  • p-AKT

Cite this